ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1660

Role of Immune System Cells and Induction of Netosis-Mediated Cell Death in the Development of Atherosclerosis in Ankylosing Spondylitis

Yolanda Jiménez-Gómez1, Pilar Font-Ugalde1, Patricia Ruiz-Limon2, Maria Carmen Abalos-Aguilera2, M. Carmen Castro-Villegas3, Nuria Barbarroja1, Carlos Perez-Sanchez1, Ivan Arias de la Rosa2, Isabel Arias2, Rafaela Ortega-Castro1, Jerusalem Calvo-Gutierrez1, Chary Lopez-Pedrera1, Alejandro Escudero-Contreras2 and Eduardo Collantes-Estévez1, 1Rheumatology service, IMIBIC/Reina Sofia Hospital/University of Cordoba, Cordoba, Spain, 2Rheumatology Service, IMIBIC/Reina Sofia Hospital/University of Cordoba, Cordoba, Spain, 3Rheumatology Service, IMIBIC/Reina Sofia Hospital/University of Cordoba, Córdoba, Spain

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: Ankylosing spondylitis (AS), atherosclerosis and inflammation, ROS

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 14, 2016

Title: Spondylarthropathies Psoriatic Arthritis – Pathogenesis, Etiology - Poster I

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose:  Ankylosing Spondylitis (AS) is a chronic inflammatory disease associated with the development of atherosclerosis. Our aims were: 1) To evaluate the involvement of immune system cells and NETosis in the atherosclerosis process in AS patients. 2) To analyze in vitro the role of leukocyte subsets in the endothelial function.

Methods:  Thirty four AS patients and 34 healthy donors (HDs) were included in the study. Endothelial function was determined by the post occlusive hyperaemia test using Laser-Doppler. The expression of 84 genes related to atherosclerosis was determined in pooled RNA samples from peripheral blood mononuclear cells (PBMCs) of patients and HDs (n=3 each) by PCR array. Validation of several differentially expressed genes in PBMCs and the expression of various markers of oxidative stress and inflammation was quantified in leukocyte subsets. In neutrophils, NETosis markers and cell death by Sytox staining were also analyzed. Plasma DNA was quantified by fluorimetry. In vitro co-cultures of endothelial cells (HUVEC) with PBMCs or neutrophils from AS patients were performed.

Results: AS patients showed a prominent endothelial dysfunction, along with a significant alteration (fold change ≥ 2) in the expression of 50 genes related to atherosclerosis in PBMCs. Validation and expression studies showed that lymphocytes of AS patients exhibited an increase of inflammatory markers (STAT3, TNFα, IL1α, IL1β, IL6, IL23, IL2, ERAP1, IL10, IL5 mRNA), nitric oxide synthase (NOS) enzymes (NOS3 mRNA), and genes involved in adhesion (SELL, CDH5, THBS4 mRNA). In turn, monocytes displayed an augmented expression of inflammatory markers (STAT3, IFNγ, IL5, SPP1) and adhesion molecules (VCAM1, SELL), as well as a decrease in mRNA for IL6 and adhesive glycoprotein trombospondin 4 (THBS4). Neutrophils from AS patients showed a significant increase in NETosis and extruded plasma DNA levels, the latter associated with endothelial dysfunction present in AS. In addition, an increase of inflammatory markers (STAT3, TNFα, IL1β, IL1α, IL5 mRNA), adhesion molecules (ICAM1, SELL mRNA) and NOS3 mRNA was also found in this cell type. Oxidative status-related analyses demonstrated that leukocyte subsets from AS patients displayed an increase in oxidative stress and mitochondrial membrane potential, along with an alteration of TAC and NO at plasma levels. In vitro treatment of HUVECs with PBMCs or neutrophils from AS patients promoted an altered activity of the endothelial cells, which displayed altered expression of adhesion molecules, oxidative stress markers, cytokines and NOS enzymes, all of them associated to the pro-atherogenic profile of these patients.

Conclusion: 1) Leukocyte subsets from AS patients display an altered expression profile of key genes involved in the development of atherosclerosis. 2) NETosis is a cellular death mechanism occurring in AS, whose induction may act a key mediator of endothelial dysfunction in these patients. 3) That highly inflammatory PBMCs and neutrophils are responsible, at least partially, for the endothelial alteration displayed by AS patients. Funded by JA PI-0314-2012, SER


Disclosure: Y. Jiménez-Gómez, None; P. Font-Ugalde, None; P. Ruiz-Limon, None; M. C. Abalos-Aguilera, None; M. C. Castro-Villegas, None; N. Barbarroja, None; C. Perez-Sanchez, None; I. Arias de la Rosa, None; I. Arias, None; R. Ortega-Castro, None; J. Calvo-Gutierrez, None; C. Lopez-Pedrera, None; A. Escudero-Contreras, None; E. Collantes-Estévez, None.

To cite this abstract in AMA style:

Jiménez-Gómez Y, Font-Ugalde P, Ruiz-Limon P, Abalos-Aguilera MC, Castro-Villegas MC, Barbarroja N, Perez-Sanchez C, Arias de la Rosa I, Arias I, Ortega-Castro R, Calvo-Gutierrez J, Lopez-Pedrera C, Escudero-Contreras A, Collantes-Estévez E. Role of Immune System Cells and Induction of Netosis-Mediated Cell Death in the Development of Atherosclerosis in Ankylosing Spondylitis [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/role-of-immune-system-cells-and-induction-of-netosis-mediated-cell-death-in-the-development-of-atherosclerosis-in-ankylosing-spondylitis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/role-of-immune-system-cells-and-induction-of-netosis-mediated-cell-death-in-the-development-of-atherosclerosis-in-ankylosing-spondylitis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology